Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (Hereinafter: "Immunotherapy") in NSCLC in Palliative Therapy
Clinical trial NCT05426668 · RECRUITING
Trial details
- NCT number
- NCT05426668
- Sponsor
- Karsten Gavenis
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-24
- Primary completion
- 2027-11-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.